{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:25:16Z","timestamp":1792801516895,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Gait disturbance and imbalance are the major symptoms of Parkinson disease (PD), with fall being the most undesirable consequence. However, few effective evidence-based treatments are available for alleviating these symptoms and preventing falls. Cholinesterase inhibitors (ChEIs) are a well-established treatment for PD dementia with possible impacts on gait, balance, and fall reduction. The present study involved a meta-analysis of randomized controlled trials (RCTs) to investigate the effects of ChEIs on gait, balance, and fall in patients with PD. We searched for studies using the PubMed, Embase, and Web of Science databases. The major outcomes were effects on gait parameters, balance, and fall. This study was registered with PROSPERO (CRD42021254733). Five RCTs were included in the present meta-analysis. ChEIs did not significantly increase gait speed in PD patients (mean difference [MD]: 0.03\u2009m\/s, 95% confidence interval [CI]: \u22120.02 to 0.07,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.29). However, ChEI treatment significantly decreased step or stride variability during the single task (standard MD: \u22120.43, 95% CI\u2009=\u2009\u22120.79 to \u22120.06,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.02). Regarding fall and balance, trending but nonsignificant beneficial effects were observed with ChEI treatment. In conclusion, although ChEI treatment did not significantly improve gait speed and reduce fall, it can significantly reduce step or stride variability. Considering that gait disorder is a challenging issue in patients with PD and that ChEIs are generally tolerable, the present meta-analysis may provide more evidence for the benefit of ChEIs on PD gait disturbance as an alternative treatment consideration.\n                  <\/jats:p>","DOI":"10.1038\/s41531-021-00251-1","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T06:08:02Z","timestamp":1637820482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cholinesterase inhibitors for gait, balance, and fall in Parkinson disease: a meta-analysis"],"prefix":"10.1038","volume":"7","author":[{"given":"Jia-Hung","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6722-1153","authenticated-orcid":false,"given":"Tsai-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Tai","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"key":"251_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau, L. M. & Breteler, M. M. Epidemiology of Parkinson\u2019s disease. Lancet Neurol. 5, 525\u2013535 (2006).","journal-title":"Lancet Neurol."},{"key":"251_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/archneurol.2008.561","volume":"66","author":"SY Lim","year":"2009","unstructured":"Lim, S. Y., Fox, S. H. & Lang, A. E. Overview of the extranigral aspects of Parkinson disease. Arch. Neurol. 66, 167\u2013172 (2009).","journal-title":"Arch. Neurol."},{"key":"251_CR3","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1001\/archneur.58.10.1611","volume":"58","author":"J Jankovic","year":"2001","unstructured":"Jankovic, J. & Kapadia, A. S. Functional decline in Parkinson disease. Arch. Neurol. 58, 1611\u20131615 (2001).","journal-title":"Arch. Neurol."},{"key":"251_CR4","first-page":"355","volume":"29","author":"O Celiker","year":"2019","unstructured":"Celiker, O., Demir, G., Kocaoglu, M., Altug, F. & Acar, F. Comparison of subthalamic nucleus vs. globus pallidus interna deep brain stimulation in terms of gait and balance; a two year follow-up study. Turk. Neurosurg. 29, 355\u2013361 (2019).","journal-title":"Turk. Neurosurg."},{"key":"251_CR5","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1212\/01.wnl.0000313835.33830.80","volume":"70","author":"D Muslimovic","year":"2008","unstructured":"Muslimovic, D., Post, B., Speelman, J. D., Schmand, B. & de Haan, R. J. Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology 70, 2241\u20132247 (2008).","journal-title":"Neurology"},{"key":"251_CR6","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/mds.27195","volume":"32","author":"A Fasano","year":"2017","unstructured":"Fasano, A., Canning, C. G., Hausdorff, J. M., Lord, S. & Rochester, L. Falls in Parkinson\u2019s disease: a complex and evolving picture. Mov. Disord. 32, 1524\u20131536 (2017).","journal-title":"Mov. Disord."},{"key":"251_CR7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.parkreldis.2015.03.028","volume":"21","author":"M Amboni","year":"2015","unstructured":"Amboni, M. et al. Prevalence and associated features of self-reported freezing of gait in Parkinson disease: the DEEP FOG study. Parkinsonism Relat. Disord. 21, 644\u2013649 (2015).","journal-title":"Parkinsonism Relat. Disord."},{"key":"251_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/mds.21850","volume":"23","author":"M Amboni","year":"2008","unstructured":"Amboni, M., Cozzolino, A., Longo, K., Picillo, M. & Barone, P. Freezing of gait and executive functions in patients with Parkinson\u2019s disease. Mov. Disord. 23, 395\u2013400 (2008).","journal-title":"Mov. Disord."},{"key":"251_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1037\/neu0000331","volume":"31","author":"RD Salazar","year":"2017","unstructured":"Salazar, R. D. et al. Dual tasking in Parkinson\u2019s disease: cognitive consequences while walking. Neuropsychology 31, 613\u2013623 (2017).","journal-title":"Neuropsychology"},{"key":"251_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00391-004-0176-7","volume":"37","author":"MB van Iersel","year":"2004","unstructured":"van Iersel, M. B., Hoefsloot, W., Munneke, M., Bloem, B. R. & Olde Rikkert, M. G. Systematic review of quantitative clinical gait analysis in patients with dementia. Z. Gerontol. Geriatr. 37, 27\u201332 (2004).","journal-title":"Z. Gerontol. Geriatr."},{"key":"251_CR11","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1056\/NEJM198812293192604","volume":"319","author":"ME Tinetti","year":"1988","unstructured":"Tinetti, M. E., Speechley, M. & Ginter, S. F. Risk factors for falls among elderly persons living in the community. N. Engl. J. Med. 319, 1701\u20131707 (1988).","journal-title":"N. Engl. J. Med."},{"key":"251_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/mds.21720","volume":"23","author":"G Yogev-Seligmann","year":"2008","unstructured":"Yogev-Seligmann, G., Hausdorff, J. M. & Giladi, N. The role of executive function and attention in gait. Mov. Disord. 23, 329\u2013342 (2008).","journal-title":"Mov. Disord."},{"key":"251_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0966-6362(01)00156-4","volume":"16","author":"M Woollacott","year":"2002","unstructured":"Woollacott, M. & Shumway-Cook, A. Attention and the control of posture and gait: a review of an emerging area of research. Gait Posture 16, 1\u201314 (2002).","journal-title":"Gait Posture"},{"key":"251_CR14","doi-asserted-by":"publisher","first-page":"16522","DOI":"10.1523\/JNEUROSCI.2545-13.2013","volume":"33","author":"A Kucinski","year":"2013","unstructured":"Kucinski, A., Paolone, G., Bradshaw, M., Albin, R. L. & Sarter, M. Modeling fall propensity in Parkinson\u2019s disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal\u2013dopaminergic deafferentation. J. Neurosci. 33, 16522\u201316539 (2013).","journal-title":"J. Neurosci."},{"key":"251_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.expneurol.2014.04.032","volume":"257","author":"M Sarter","year":"2014","unstructured":"Sarter, M., Albin, R. L., Kucinski, A. & Lustig, C. Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function. Exp. Neurol. 257, 120\u2013129 (2014).","journal-title":"Exp. Neurol."},{"key":"251_CR16","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s00213-018-5150-y","volume":"236","author":"A Koshy Cherian","year":"2019","unstructured":"Koshy Cherian, A., Kucinski, A., Wu, R., de Jong, I. E. M. & Sarter, M. Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson\u2019s disease. Psychopharmacology 236, 1701\u20131715 (2019).","journal-title":"Psychopharmacology"},{"key":"251_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/ejn.13354","volume":"45","author":"A Kucinski","year":"2017","unstructured":"Kucinski, A., de Jong, I. E. & Sarter, M. Reducing falls in Parkinson\u2019s disease: interactions between donepezil and the 5-HT(6) receptor antagonist idalopirdine on falls in a rat model of impaired cognitive control of complex movements. Eur. J. Neurosci. 45, 217\u2013231 (2017).","journal-title":"Eur. J. Neurosci."},{"key":"251_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.parkreldis.2019.02.017","volume":"63","author":"R Morris","year":"2019","unstructured":"Morris, R. et al. Overview of the cholinergic contribution to gait, balance and falls in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 63, 20\u201330 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"251_CR19","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa041470","volume":"351","author":"M Emre","year":"2004","unstructured":"Emre, M. et al. Rivastigmine for dementia associated with Parkinson\u2019s disease. N. Engl. J. Med. 351, 2509\u20132518 (2004).","journal-title":"N. Engl. J. Med."},{"key":"251_CR20","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1136\/jnnp.2004.050682","volume":"76","author":"B Ravina","year":"2005","unstructured":"Ravina, B. et al. Donepezil for dementia in Parkinson\u2019s disease: a randomised, double blind, placebo controlled, crossover study. J. Neurol. Neurosurg. Psychiatry 76, 934\u2013939 (2005).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"251_CR21","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/mds.25098","volume":"27","author":"B Dubois","year":"2012","unstructured":"Dubois, B. et al. Donepezil in Parkinson\u2019s disease dementia: a randomized, double-blind efficacy and safety study. Mov. Disord. 27, 1230\u20131238 (2012).","journal-title":"Mov. Disord."},{"key":"251_CR22","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1136\/jnnp-2018-318107","volume":"89","author":"H Sawada","year":"2018","unstructured":"Sawada, H. et al. Early use of donepezil against psychosis and cognitive decline in Parkinson\u2019s disease: a randomised controlled trial for 2 years. J. Neurol. Neurosurg. Psychiatry 89, 1332\u20131340 (2018).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"251_CR23","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1212\/WNL.0b013e3181f6128c","volume":"75","author":"KA Chung","year":"2010","unstructured":"Chung, K. A., Lobb, B. M., Nutt, J. G. & Horak, F. B. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology 75, 1263\u20131269 (2010).","journal-title":"Neurology"},{"key":"251_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.parkreldis.2019.10.022","volume":"69","author":"M Mancini","year":"2019","unstructured":"Mancini, M. et al. Effects of augmenting cholinergic neurotransmission on balance in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 69, 40\u201347 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"251_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000438824","volume":"74","author":"Z Li","year":"2015","unstructured":"Li, Z. et al. Impact of rivastigmine on cognitive dysfunction and falling in Parkinson\u2019s disease patients. Eur. Neurol. 74, 86\u201391 (2015).","journal-title":"Eur. Neurol."},{"key":"251_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1474-4422(15)00389-0","volume":"15","author":"EJ Henderson","year":"2016","unstructured":"Henderson, E. J. et al. Rivastigmine for gait stability in patients with Parkinson\u2019s disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 15, 249\u2013258 (2016).","journal-title":"Lancet Neurol."},{"key":"251_CR27","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/mds.28214","volume":"35","author":"S Stuart","year":"2020","unstructured":"Stuart, S. et al. Prefrontal cortex activity and gait in Parkinson\u2019s disease with cholinergic and dopaminergic therapy. Mov. Disord. 35, 2019\u20132027 (2020).","journal-title":"Mov. Disord."},{"key":"251_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.neubiorev.2018.12.017","volume":"100","author":"J Wilson","year":"2019","unstructured":"Wilson, J., Allcock, L., Mc Ardle, R., Taylor, J.-P. & Rochester, L. The neural correlates of discrete gait characteristics in ageing: a structured review. Neurosci. Biobehav. Rev. 100, 344\u2013369 (2019).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"251_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00695605","volume":"64","author":"P Gaspar","year":"1984","unstructured":"Gaspar, P. & Gray, F. Dementia in idiopathic Parkinson\u2019s disease. A neuropathological study of 32 cases. Acta Neuropathol. 64, 43\u201352 (1984).","journal-title":"Acta Neuropathol."},{"key":"251_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/jnnp-2013-305062","volume":"85","author":"JE Lee","year":"2014","unstructured":"Lee, J. E. et al. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 85, 7\u201316 (2014).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"251_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00221-013-3412-9","volume":"226","author":"G Yogev-Seligmann","year":"2013","unstructured":"Yogev-Seligmann, G., Giladi, N., Gruendlinger, L. & Hausdorff, J. M. The contribution of postural control and bilateral coordination to the impact of dual tasking on gait. Exp. Brain Res. 226, 81\u201393 (2013).","journal-title":"Exp. Brain Res."},{"key":"251_CR32","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/j.1460-9568.2005.04298.x","volume":"22","author":"G Yogev","year":"2005","unstructured":"Yogev, G. et al. Dual tasking, gait rhythmicity, and Parkinson\u2019s disease: which aspects of gait are attention demanding? Eur. J. Neurosci. 22, 1248\u20131256 (2005).","journal-title":"Eur. J. Neurosci."},{"key":"251_CR33","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00221-011-2551-0","volume":"210","author":"M Plotnik","year":"2011","unstructured":"Plotnik, M., Giladi, N., Dagan, Y. & Hausdorff, J. M. Postural instability and fall risk in Parkinson\u2019s disease: impaired dual tasking, pacing, and bilateral coordination of gait during the \u201cON\u201d medication state. Exp. Brain Res. 210, 529\u2013538 (2011).","journal-title":"Exp. Brain Res."},{"key":"251_CR34","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1111\/ejn.12666","volume":"40","author":"DA MacLaren","year":"2014","unstructured":"MacLaren, D. A., Santini, J. A., Russell, A. L., Markovic, T. & Clark, S. D. Deficits in motor performance after pedunculopontine lesions in rats-impairment depends on demands of task. Eur. J. Neurosci. 40, 3224\u20133236 (2014).","journal-title":"Eur. J. Neurosci."},{"key":"251_CR35","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1172\/JCI42642","volume":"120","author":"C Karachi","year":"2010","unstructured":"Karachi, C. et al. Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J. Clin. Invest. 120, 2745\u20132754 (2010).","journal-title":"J. Clin. Invest."},{"key":"251_CR36","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1212\/WNL.0b013e3181c1ded6","volume":"73","author":"NI Bohnen","year":"2009","unstructured":"Bohnen, N. I. et al. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology 73, 1670\u20131676 (2009).","journal-title":"Neurology"},{"key":"251_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0966-6362(03)00030-4","volume":"18","author":"F Danion","year":"2003","unstructured":"Danion, F., Varraine, E., Bonnard, M. & Pailhous, J. Stride variability in human gait: the effect of stride frequency and stride length. Gait Posture 18, 69\u201377 (2003).","journal-title":"Gait Posture"},{"key":"251_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00221-002-1354-8","volume":"149","author":"JM Hausdorff","year":"2003","unstructured":"Hausdorff, J. M. et al. Impaired regulation of stride variability in Parkinson\u2019s disease subjects with freezing of gait. Exp. Brain Res. 149, 187\u2013194 (2003).","journal-title":"Exp. Brain Res."},{"key":"251_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000489927","volume":"45","author":"S Byun","year":"2018","unstructured":"Byun, S. et al. Gait variability can predict the risk of cognitive decline in cognitively normal older people. Dement. Geriatr. Cogn. Disord. 45, 251\u2013261 (2018).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"251_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0022-510X(03)00104-7","volume":"212","author":"JD Schaafsma","year":"2003","unstructured":"Schaafsma, J. D. et al. Gait dynamics in Parkinson\u2019s disease: relationship to Parkinsonian features, falls and response to levodopa. J. Neurol. Sci. 212, 47\u201353 (2003).","journal-title":"J. Neurol. Sci."},{"key":"251_CR41","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/alz.12298","volume":"17","author":"F Pieruccini-Faria","year":"2021","unstructured":"Pieruccini-Faria, F. et al. Gait variability across neurodegenerative and cognitive disorders: results from the Canadian Consortium of Neurodegeneration in Aging (CCNA) and the Gait and Brain Study. Alzheimers Dement. 17, 1317\u20131328 (2021).","journal-title":"Alzheimers Dement."},{"key":"251_CR42","doi-asserted-by":"publisher","first-page":"e106561","DOI":"10.1371\/journal.pone.0106561","volume":"9","author":"KA Ehgoetz Martens","year":"2014","unstructured":"Ehgoetz Martens, K. A., Ellard, C. G. & Almeida, Q. J. Does anxiety cause freezing of gait in Parkinson\u2019s disease? PLoS ONE 9, e106561 (2014).","journal-title":"PLoS ONE"},{"key":"251_CR43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0306-4522(03)00095-2","volume":"119","author":"K Takakusaki","year":"2003","unstructured":"Takakusaki, K., Habaguchi, T., Ohtinata-Sugimoto, J., Saitoh, K. & Sakamoto, T. Basal ganglia efferents to the brainstem centers controlling postural muscle tone and locomotion: a new concept for understanding motor disorders in basal ganglia dysfunction. Neuroscience 119, 293\u2013308 (2003).","journal-title":"Neuroscience"},{"key":"251_CR44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.14802\/jmd.15018","volume":"8","author":"JH Park","year":"2015","unstructured":"Park, J. H., Kang, Y. J. & Horak, F. B. What is wrong with balance in Parkinson\u2019s disease? J. Mov. Disord. 8, 109\u2013114 (2015).","journal-title":"J. Mov. Disord."},{"key":"251_CR45","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.wneu.2017.02.110","volume":"102","author":"JW Wang","year":"2017","unstructured":"Wang, J. W. et al. Deep brain stimulation of pedunculopontine nucleus for postural instability and gait disorder after Parkinson disease: a meta-analysis of individual patient data. World Neurosurg. 102, 72\u201378 (2017).","journal-title":"World Neurosurg."},{"key":"251_CR46","first-page":"906274","volume":"2013","author":"NE Allen","year":"2013","unstructured":"Allen, N. E., Schwarzel, A. K. & Canning, C. G. Recurrent falls in Parkinson\u2019s disease: a systematic review. Parkinsons Dis. 2013, 906274 (2013).","journal-title":"Parkinsons Dis."},{"key":"251_CR47","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/alz.12298","volume":"17","author":"F Pieruccini-Faria","year":"2021","unstructured":"Pieruccini-Faria, F. et al. Gait variability across neurodegenerative and cognitive disorders: results from the Canadian Consortium of neurodegeneration in aging (CCNA) and the Gait and Brain Study. Alzheimer\u2019s Dement. 17, 1317\u20131328 (2021).","journal-title":"Alzheimer\u2019s Dement."},{"key":"251_CR48","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.gaitpost.2014.10.022","volume":"41","author":"A Delval","year":"2015","unstructured":"Delval, A. et al. Gait and attentional performance in freezers under methylphenidate. Gait Posture 41, 384\u2013388 (2015).","journal-title":"Gait Posture"},{"key":"251_CR49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27602","volume":"34","author":"K Seppi","year":"2019","unstructured":"Seppi, K. et al. Update on treatments for nonmotor symptoms of Parkinson\u2019s disease-an evidence-based medicine review. Mov. Disord. 34, 180\u2013198 (2019).","journal-title":"Mov. Disord."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00251-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T21:12:20Z","timestamp":1675890740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00251-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["251"],"URL":"https:\/\/doi.org\/10.1038\/s41531-021-00251-1","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,25]]},"assertion":[{"value":"29 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}